BGI Genomics Statistics

Total Valuation

BGI Genomics has a market cap or net worth of CNY 17.88 billion. The enterprise value is 14.63 billion.

Market Cap	17.88B
Enterprise Value	14.63B

Important Dates

The last earnings date was Saturday, April 26, 2025.

Earnings Date	Apr 26, 2025
Ex-Dividend Date	Jul 4, 2024

Share Statistics

BGI Genomics has 381.35 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	381.35M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	10.86%
Float	197.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.62
PB Ratio	1.93
P/TBV Ratio	2.05
P/FCF Ratio	n/a
P/OCF Ratio	186.77
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.20
EV / Sales	3.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-33.72

Financial Position

The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.05.

Current Ratio	2.42
Quick Ratio	2.13
Debt / Equity	0.05
Debt / EBITDA	12.65
Debt / FCF	-1.09
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -9.46% and return on invested capital (ROIC) is -2.54%.

Return on Equity (ROE)	-9.46%
Return on Assets (ROA)	-1.96%
Return on Invested Capital (ROIC)	-2.54%
Return on Capital Employed (ROCE)	-4.22%
Revenue Per Employee	1.03M
Profits Per Employee	-240,589
Employee Count	3,752
Asset Turnover	0.30
Inventory Turnover	3.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.97% in the last 52 weeks. The beta is 0.97, so BGI Genomics's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+17.97%
50-Day Moving Average	55.98
200-Day Moving Average	44.91
Relative Strength Index (RSI)	34.23
Average Volume (20 Days)	5,273,750

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BGI Genomics had revenue of CNY 3.87 billion and -902.69 million in losses. Loss per share was -2.19.

Revenue	3.87B
Gross Profit	1.60B
Operating Income	-409.23M
Pretax Income	-886.11M
Net Income	-902.69M
EBITDA	20.64M
EBIT	-409.23M
Loss Per Share	-2.19

Full Income Statement

Balance Sheet

The company has 4.31 billion in cash and 472.70 million in debt, giving a net cash position of 3.84 billion or 10.06 per share.

Cash & Cash Equivalents	4.31B
Total Debt	472.70M
Net Cash	3.84B
Net Cash Per Share	10.06
Equity (Book Value)	9.27B
Book Value Per Share	22.15
Working Capital	4.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 95.72 million and capital expenditures -529.48 million, giving a free cash flow of -433.76 million.

Operating Cash Flow	95.72M
Capital Expenditures	-529.48M
Free Cash Flow	-433.76M
FCF Per Share	-1.14

Full Cash Flow Statement

Margins

Gross margin is 41.47%, with operating and profit margins of -10.58% and -23.34%.

Gross Margin	41.47%
Operating Margin	-10.58%
Pretax Margin	-22.92%
Profit Margin	-23.34%
EBITDA Margin	0.53%
EBIT Margin	-10.58%
FCF Margin	n/a

Dividends & Yields

BGI Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-90.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	-5.05%
FCF Yield	-2.43%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a